MIR Preclinical Services Our company is a contract research organization (CRO) located in Ann Arbor, Michigan. We specialize in the preclinical assessments and evaluation of novel anti-cancer and anti-inflammatory therapeutic agents. We offer additional services such as preclinical efficacy testing, non-invasive imaging, pharmacodynamics, pharmacokinetics and consulting. Our company employs a wide array of novel imaging technologies including preclinical MRI, CT (µCT), high resolution PET (µPET), bioluminescence and fluorescence imaging to measure response to therapy at anatomical, functional, and molecular levels.